PNP Therapeutics: PNP Therapeutics, Inc. Receives Orphan Drug Status For Gedeptin

BIRMINGHAM, Ala., June 16, 2015 /PRNewswire-USNewswire/ -- PNP Therapeutics Inc. announced today the Food and Drug Administration has granted orphan drug status to Gedeptin, the Company's lead product candidate (adenoviral vector expressing E. coli purine nucleoside phosphorylase gene) for...